tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

FDMT Stock Latest News

4D Molecular price target lowered to $40 from $42 at BofA
The Fly4D Molecular price target lowered to $40 from $42 at BofA
18d ago
FDMT
4D Molecular announces first patients enrolled in 4FRONT-1 Phase 3 trial
PremiumThe Fly
4D Molecular announces first patients enrolled in 4FRONT-1 Phase 3 trial
18d ago
FDMT
4D Molecular price target lowered to $28 from $30 at Chardan
PremiumThe Fly
4D Molecular price target lowered to $28 from $30 at Chardan
24d ago
FDMT
4D Molecular price target lowered to $35 from $39 at RBC Capital
PremiumThe Fly
4D Molecular price target lowered to $35 from $39 at RBC Capital
25d ago
FDMT
Promising Developments in 4D Molecular Therapeutics’ Gene Therapy Program Justify Buy Rating
PremiumRatings
Promising Developments in 4D Molecular Therapeutics’ Gene Therapy Program Justify Buy Rating
25d ago
FDMT
4D Molecular Therapeutics Reports Strong Clinical Progress and Financial Position
PremiumCompany Announcements4D Molecular Therapeutics Reports Strong Clinical Progress and Financial Position
26d ago
FDMT
Optimistic Buy Rating for 4D-150 Driven by PRISM Study’s Promising Results in Treating Wet Age-Related Macular Degeneration
Premium
Ratings
Optimistic Buy Rating for 4D-150 Driven by PRISM Study’s Promising Results in Treating Wet Age-Related Macular Degeneration
2M ago
FDMT
4D Molecular price target lowered to $30 from $39 at Chardan
Premium
The Fly
4D Molecular price target lowered to $30 from $39 at Chardan
2M ago
FDMT
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
PremiumThe Fly
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
2M ago
ADVM
FDMT
Cautious ‘Hold’ Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns
PremiumRatings
Cautious ‘Hold’ Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns
2M ago
FDMT
4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials
PremiumRatings
4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials
2M ago
FDMT
Promising Prospects for 4D Molecular Therapeutics: Anticipated Growth in wAMD Treatment and Market Valuation
PremiumRatings
Promising Prospects for 4D Molecular Therapeutics: Anticipated Growth in wAMD Treatment and Market Valuation
2M ago
FDMT
4D Molecular price target lowered to $42 from $46 at BofA
PremiumThe Fly4D Molecular price target lowered to $42 from $46 at BofA
2M ago
FDMT
4D Molecular price target lowered to $6 from $8 at Morgan Stanley
Premium
The Fly
4D Molecular price target lowered to $6 from $8 at Morgan Stanley
3M ago
FDMT
4D Molecular downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
4D Molecular downgraded to Market Perform from Outperform at BMO Capital
3M ago
FDMT
4D Molecular focuses pipeline to prioritize 4D-150 in wet AMD, DME
PremiumThe Fly
4D Molecular focuses pipeline to prioritize 4D-150 in wet AMD, DME
3M ago
FDMT
4D Molecular announces interim data on 4D-150 SPECTRA clincial trial
PremiumThe Fly
4D Molecular announces interim data on 4D-150 SPECTRA clincial trial
3M ago
FDMT
4D Molecular price target lowered to $46 from $79 at BofA
PremiumThe Fly
4D Molecular price target lowered to $46 from $79 at BofA
3M ago
FDMT
4D Molecular announces publication of 4D-150 preclinical data
PremiumThe Fly
4D Molecular announces publication of 4D-150 preclinical data
3M ago
FDMT
4D Molecular initiated with an Underweight at Morgan Stanley
PremiumThe Fly4D Molecular initiated with an Underweight at Morgan Stanley
4M ago
FDMT
4D Molecular Therapeutics’ Positive Q3 and Strategic Advances
Premium
Company Announcements
4D Molecular Therapeutics’ Positive Q3 and Strategic Advances
4M ago
FDMT
4D Molecular reports Q3 EPS (79c), consensus (70c)
Premium
The Fly
4D Molecular reports Q3 EPS (79c), consensus (70c)
4M ago
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >